NexgenRx Re-Appoints Charles Burns to Board of Directors

NexgenRx Inc. has announced the re-appointment of Charles Burns to its Board of Directors. This decision is effective immediately. Burns previously served as a director from June 16, 2017, to September 30, 2024. His return is expected to bring valuable insights and leadership to the company. Thomas Corcoran, Chair and a director of NexgenRx, expressed enthusiasm about Burns's return.

NexgenRx, an independent Third-Party Administrator and Technology Solutions Provider in Canada, offers comprehensive services in claims adjudication and health benefit technology applications. Operating under a SaaS model, NexgenRx focuses on competitive, efficient solutions for plan sponsors.